| LOTUS Boston Mountain Biotech LLC
85854133 19 Feb 2013 | on 23 Jul 2021 | Designer biological cells possessing optimized growth and purity, for ... Class 001 Class 001 Chemical Products Designer biological cells possessing optimized growth and purity, for medical or clinical use Class 005 Class 005 Pharmaceutical Products The color(s) yellow and black is/are claimed as a feature of the mark. | | | LOTUS Boston Mountain Biotech LLC
85854077 19 Feb 2013 | on 23 Jul 2021 | Designer biological cells possessing optimized growth and purity, for ... Class 001 Class 001 Chemical Products Designer biological cells possessing optimized growth and purity, for medical or clinical use Class 005 Class 005 Pharmaceutical Products Designer biological cells possessing optimized growth and purity, for medical or clinical use | | | REVERA GEN Reveragen Biopharma, Inc
85466781 08 Nov 2011 | on 29 Aug 2014 | Therapeutic pharmaceutical for the treatment of neuromuscular disease,... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "REVERA" in black with the "R" capitalized and the "V" in red with "GEN" below in black having a capital "G" and a stylized "N" and a grey incomplete elliptical line runs behind the words and through the "V" and there is a solid grey bead and a small open circle on the line. Class 042 Class 042 Computer & Software Services & Scientific Services Therapeutic pharmaceutical for the treatment of neuromuscular disease | | | REVERAGEN Reveragen BioPharma, Inc
85466817 08 Nov 2011 | on 29 Aug 2014 | Therapeutic pharmaceutical for the treatment of neuromuscular disease,... Class 005 Class 005 Pharmaceutical Products The mark consists of the word "REVERAGEN" in black letters with a red "V" and an initial capital letter "R" and a capital "G" and a stylized "N" for the final "N" Class 042 Class 042 Computer & Software Services & Scientific Services The mark consists of the word "REVERAGEN" in black letters with a red "V" and an initial capital letter "R" and a capital "G" and a stylized "N" for the final "N" | |